Roche may have failed to buy out Illumina back in 2012, but now it’s trying to take up some of the gene sequencing specialist ...

By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Swiss pharmaceutical and diagnostics giant Roche ...

AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost efficiency, giving laboratories of all sizes the freedom to customise their workflows and explore a wider array of ...

Roche Diagnostics Products (Suzhou) Co Ltd has signed an agreement with the Suzhou Industrial Park (SIP) Administrative ...

By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Roche launched its next-generation gene sequencing ...

Roche debuts Axelios, a gene sequencer targeting academic and research facilities, to compete with Illumina's dominance in ...

Roche Holding received FDA acceptance of Lunsumio VELO plus Polivy for relapsed or refractory large B cell lymphoma based on ...

Roche has introduced the first test based on a new technology – called TAGS – that it believes could revolutionise testing for infectious diseases by allowing high-throughput detection to be carried ...

Roche will leverage Signature's unique expertise in both biobanks and NGS assays to develop novel diagnostics for cancer patients "Biobanks play an important role in uncovering the cause or origin of ...

Roche Diagnostics has promoted Johnny Smith to global head of communications. Smith started in the role March 1. He reports to Barbara Schädler, head of group communications for Roche, which comprises ...

Roche is adding to its diagnostic capabilities through a deal to acquire GenMark Diagnostics, a molecular diagnostics company whose technology tests for multiple pathogens—including the novel ...

Roche Diagnostics has announced a key leadership transition for its India and Neighboring Markets business. Effective August ...